M K Exim India Ltd vs Q Line Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of M K Exim (India) Ltd is ₹ 51.09 as of 23 Oct 15:30 . The P/E Ratio of M K Exim (India) Ltd changed from 3.6 on March 2021 to 8.7 on March 2026 . This represents a CAGR of 15.84% over 6 yearsThe P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of M K Exim (India) Ltd changed from ₹ 29.02 crore on March 2021 to ₹ 163.2 crore on March 2026 . This represents a CAGR of 33.35% over 6 yearsThe Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of M K Exim (India) Ltd is ₹ 0 crore as of Dec '25 .The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 . The EBITDA of M K Exim (India) Ltd is ₹ 0 crore as of Dec '25 .The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 . The Net Profit of M K Exim (India) Ltd is ₹ 0 crore as of Dec '25 .The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 . The Dividend Payout of M K Exim (India) Ltd changed from 13.18 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About M K Exim (India) Ltd

Incorporated as a private limited company in 1992, M K Exim (India) Limited was converted into a public limited company in February, 1995.
It was promoted by K L Khanchandani, Daya Ram Khanchandani and Shyam Khanchandani.
The Company is engaged in business of export of fabrics and Distributorship of Cosmetics (FMCG) products consisting of personal care and personal hygiene products of internationally reputed brands. The company set up an unit at Jaipur to manufacture synthetic fabrics.
Commercial production commenced in Apr.'94.
It exports most of the production to the Middle East countries. In 1995-96, the company envisaged an expansion-cum-diversification project to augment the total production of synthetic fabrics and to start manufacturing knitted fabrics at Jaipur, for the export purpose.

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

FAQs for the comparison of M K Exim (India) Ltd and Q-Line Biotech Ltd

Which company has a larger market capitalization, M K Exim (India) Ltd or Q-Line Biotech Ltd?

Market cap of M K Exim (India) Ltd is 206 Cr while Market cap of Q-Line Biotech Ltd is 1,235 Cr

What are the key factors driving the stock performance of M K Exim (India) Ltd and Q-Line Biotech Ltd?

The stock performance of M K Exim (India) Ltd and Q-Line Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for M K Exim (India) Ltd and Q-Line Biotech Ltd?

As of October 25, 2026, the M K Exim (India) Ltd stock price is INR ₹51.09. On the other hand, Q-Line Biotech Ltd stock price is INR ₹529.55.

How do dividend payouts of M K Exim (India) Ltd and Q-Line Biotech Ltd compare?

To compare the dividend payouts of M K Exim (India) Ltd and Q-Line Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.